Deutsche Bank AG Sells 69,708 Shares of CME Group Inc. $CME

Deutsche Bank AG reduced its holdings in CME Group Inc. (NASDAQ:CME) by 4.3% in the fourth quarter, HoldingsChannel reports. The firm owned 1,542,865 shares of the financial services provider’s stock after selling 69,708 shares during the period. Deutsche Bank AG’s holdings in CME Group were worth $421,326,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in CME. Norges Bank bought a new stake in CME Group in the fourth quarter worth approximately $1,523,241,000. Sanders Capital LLC bought a new stake in shares of CME Group during the third quarter valued at approximately $1,006,932,000. Strive Asset Management LLC bought a new stake in shares of CME Group during the third quarter valued at approximately $636,487,000. Life Cycle Investment Partners Ltd bought a new stake in shares of CME Group during the fourth quarter valued at approximately $217,656,000. Finally, Viking Global Investors LP bought a new stake in shares of CME Group during the second quarter valued at approximately $164,648,000. 87.75% of the stock is currently owned by institutional investors.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, a regulated cash-settled product tied to a benchmark of major cryptocurrencies including Bitcoin, Solana, XRP and others. The new offering could attract more trading volume from investors seeking broad crypto exposure and hedging tools. Article Title
• Positive Sentiment: CME Group and Morningstar announced an exclusive multi-year licensing agreement to launch derivatives based on Morningstar equity index benchmarks, opening a new product line tied to indexes that underpin more than $3 trillion in linked assets. Article Title
• Positive Sentiment: Shareholders maintained CME’s Class B governance structure and rejected a bid to end those director election rights, removing a potential governance overhang and preserving the company’s current control framework. Article Title
• Neutral Sentiment: CME also announced its second-quarter 2026 earnings release date for July 22, which is mainly a scheduling update but keeps attention on upcoming results. Article Title
• Neutral Sentiment: Reports about short interest and options activity suggest traders are watching CME closely, but those items do not yet point to a clear fundamental catalyst. Article Title

CME Group Trading Up 3.1%

Shares of CME Group stock opened at $263.80 on Thursday. The stock has a fifty day simple moving average of $286.00 and a 200 day simple moving average of $288.28. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16. The company has a market capitalization of $95.59 billion, a P/E ratio of 22.51, a price-to-earnings-growth ratio of 2.86 and a beta of 0.21. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the company posted $2.80 earnings per share. CME Group’s revenue was up 14.5% compared to the same quarter last year. On average, sell-side analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.0%. CME Group’s dividend payout ratio is 44.37%.

Insider Buying and Selling

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares in the company, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the transaction, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CME has been the subject of several recent research reports. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a report on Sunday, April 26th. TD Cowen decreased their price objective on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Jefferies Financial Group decreased their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Barclays decreased their price objective on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a report on Thursday, April 23rd. Finally, Morgan Stanley decreased their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $305.29.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.